ANB-102

N/A

Report date: 2025/05/14 15:50:24

Base Information

Drug NameANB-102
Drug Alias NameANB102ANB-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-Type lectin domain family 4 member C modulators
TargetsC-Type lectin domain family 4 member C
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentessa Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A